Phosphorylcholine-tuftsin conjugate for treating ocular inflammation
AssigneeTarsius Pharma Ltd.
InventorsDaphne HAIM-LANGFORD, Zohar MILMAN
Life of this patent
Estimating the term…
Abstract
Methods of treating or preventing ocular inflammation in a subject in need thereof, and methods of reducing the dose of a steroid administered to a subject suffering from ocular inflammation, comprising administering to an eye of the subject a pharmaceutical composition a phosphorylcholine-tuftsin conjugate comprising at least one phosphorylcholine moiety or a derivative thereof and tuftsin or a derivative thereof are provided.
Claims22
A method for treating or preventing ocular inflammation in a subject in need thereof, the method comprising administering to an eye of said subject a pharmaceutical composition comprising a very low dose of a phosphorylcholine-tuftsin conjugate comprising at least one phosphorylcholine moiety or a derivative thereof and tuftsin or a derivative thereof.
A method of reducing a dose of a steroid administered to a subject suffering from ocular inflammation, the method comprising administering to an eye of said subject a pharmaceutical composition comprising a phosphorylcholine-tuftsin conjugate comprising at least one phosphorylcholine moiety or a derivative thereof and tuftsin or a derivative thereof.
(canceled)
(canceled)
Dependencies are inferred from the claim text.